Primary record
Propanamide, N-(4-(2,2-dimethyl-1-oxopropyl)-5-((((2-(ethylamino)ethyl)sulfonyl) amino)methyl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl)-2,2-dimethyl-, (-)-
- 库存
- 7,454 克
- 纯度
- 99.1 %
- CAS
- 910634-41-2
化合物标识与属性
- CAS
- 910634-41-2
- PubChem CID
- 25167017
- SMILES
- CCNCCS(=O)(=O)NC[C@@]1(N(N=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)C2=CC=CC=C2
- Canonical SMILES
- CCNCCS(=O)(=O)NC[C@@]1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C
名称与同义词
- Litronesib
- litronesibum
- 910634-41-2
- Litronesib [USAN]
- Litronesib [USAN:INN]
- KF 89617
- LITRONESIB [INN]
- Litronesib (USAN/INN)
- RefChem:924836
- 6611F8KYCV
- UNII-6611F8KYCV
- LY2523355
- KF89617
- D0W9SL
- LITRONESIB [WHO-DD]
- LY-2523355
- SCHEMBL368284
- LY 2523355
- orb1709257
- CHEMBL2105661
- KF-89617
- C23H37N5O4S2
- GLXC-15259
- BDBM50463316
- MFCD19442197
- NSC789722
- ZINC56898863
- AKOS030526983
- CS-5194
- DB11861
- NSC-789722
- SB18860
- AN-26576
- DA-65014
- HY-14846
- MS-29500
- NS00072777
- J3.094.898J
- D09636
- F85314
- LY-2523355;KF-89617
- 634D412
- A917117
- BRD-K83029223-001-01-3
- Q27263928
- (-)-N-[4-(2,2-Dimethylpropanoyl)-5-[[2-(ethylamino)ethanesulfonamido]methyl]-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide
- N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide
- Propanamide, N-(4-(2,2-dimethyl-1-oxopropyl)-5-((((2-(ethylamino)ethyl)sulfonyl) amino)methyl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl)-2,2-dimethyl-, (-)-
- (R)-N-(5-(((2-(Ethylamino)ethyl)sulfonamido)methyl)-5-phenyl-4-pivaloyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)pivalamide
- (R)-N-(5-((2-(ethylamino)ethylsulfonamido)methyl)-5-phenyl-4-pivaloyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)pivalamide.
- N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-propanamide
- (-)-N-(4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5-phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl)-2,2-dimethyl-propionamide
- (-)-N-(4-(2,2-DIMETHYLPROPANOYL)-5-((((2-(ETHYLAMINO)ETHYL)SULFONYL)AMINO)METHYL)-5- PHENYL-4,5-DIHYDRO-1,3,4-THIADIAZOL-2-YL)-2,2-DIMETHYLPROPANAMIDE
- (-)-N-(4-(2,2-dimethylpropanoyl)-5-((((2-(ethylamino)ethyl)sulfonyl)amino)methyl)-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)-2,2-dimethylpropanamide
- (-)-N-{4-(2,2-dimethylpropanoyl)-5-(({(2-(ethylamino)ethyl)sulfonyl}amino)methyl)-5- phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl}-2,2-dimethylpropanamide
- (R)-N-(4-(2,2-DIMETHYL-PROPIONYL)-5-((2-ETHYLAMINO-ETHANESULFONYLAMINO)-METHYL)-5- PHENYL-4,5-DIHYDRO-(1,3,4)THIADIAZOL-2-YL)-2,2-DIMETHYL-PROPIONAMIDE
- (R)-N-(4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5-phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl)-2,2-dimethyl-propionamide
- (R)-N-{4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5- phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl}-2,2-dimethyl-propionamiden
- Litronesib; (-)-N-[4-(2,2-Dimethylpropanoyl)-5-[[2-(ethylamino)ethanesulfonamido]methyl]-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide
- N-((5R)-4-(2,2-dimethylpropanoyl)-5-((2-(ethylamino)ethanesulfonamido)methyl)-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)-2,2-dimethylpropanamide
- N-(4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5-phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl)-2,2-dimethyl-propionamide
- N-(4-(2,2-DIMETHYLPROPIONYL)-(5R)-5-((2-ETHYLAMINO-ETHANESULFONYLAMINO)METHYL)-5-PHENYL-4,5-DIHYDRO-(1,3,4)THIADIAZOL-2-YL)-2,2-DIMETHYLPROPIONAMIDE
- N-[(2R)-2alpha-[[[[2-(Ethylamino)ethyl]sulfonyl]amino]methyl]-2-phenyl-3-(2,2-dimethylpropionyl)-2,3-dihydro-1,3,4-thiadiazole-5-yl]-2,2-dimethylpropanamide
- N-[(5R)-4-(2,2-dimethylpropanoyl)-5-{[2-(ethylamino)ethanesulfonamido]methyl}-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide
- PROPANAMIDE, N-(4-(2,2-DIMETHYL-1-OXOPROPYL)-5-((((2-(ETHYLAMINO)ETHYL)SULFONYL)AMINO)METHYL)-4,5-DIHYDRO-5-PHENYL-1,3,4-THIADIAZOL-2-YL)-2,2-DIMETHYL-, (5R)-